Oncotelic Therapeutics Inc (OTLC)

$0.07 0.00 (-2.40%)
Market Cap 29.48M
Revenue (ttm) 0.00
Net Income (ttm) -4.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 1.72
Volume 283,300
Avg Vol 138,156
Day's Range N/A - N/A
Shares Out 442.60M
Stochastic %K 0%
Beta -0.66
Analysts Strong Buy
Price Target $4.00

Company Profile

Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications in the United States. The company develops antisense and small molecule injectable drugs for the treatment of cancer. It is also developing OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer, melanoma, and glioblas...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 635 7000
Fax: 650 635 7001
Address:
29397 Agoura Road, Suite 107, Agoura Hills, United States
CEOBuysDisclosures
CEOBuysDisclosures Jul. 2 at 9:05 PM
$OTLC CEO purchased 240,000 shares at $0.04 for a total of $10,344. Trieu Vuong now owns 117,777,232 shares. https://ceo-buys.com
0 · Reply
WallStreetSignals
WallStreetSignals Jul. 2 at 5:07 PM
$OTLC 📢 Biotech Update Oncotelic Therapeutics ($OTLC) has published a peer-reviewed manuscript supporting its Deciparticle™ nanoparticle delivery platform, reinforcing the scientific foundation behind Sapu003, its investigational IV everolimus formulation now in a Phase 1b study. Worth keeping on your biotech watchlist. https://www.globenewswire.com/news-release/2026/06/29/3318946/0/en/oncotelic-announces-peer-reviewed-validation-of-deciparticle-platform-supporting-clinical-development-of-sapu003.html #OTLC #BiotechStocks #DrugDevelopment #Nanomedicine #ClinicalResearch #InvestSmart #StockNews #TheBullRunShow
0 · Reply
Techallure
Techallure Jul. 2 at 1:12 PM
$OTLC back to .03 before news
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 30 at 6:36 PM
From Hospitality to Pharma: TechForce Robotics Expanding Its Robotics-as-a-Service Platform into Laboratory Automation $NGTF $OTLC https://ibn.fm/0lbFE
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 29 at 3:46 PM
BioMedNewsBreaks — $OTLC Publishes Peer-Reviewed Validation of Deciparticle(TM) Platform https://ibn.fm/QTopP
0 · Reply
WallStreetSignals
WallStreetSignals Jun. 29 at 3:29 PM
$OTLC Breaking News | Oncotelic Therapeutics, Inc. (OTCQB: #OTLC) has published a peer-reviewed manuscript validating its innovative Deciparticle™ nanoparticle platform. This follows the development of Sapu003, an investigational intravenous formulation of everolimus currently in a Phase 1b clinical trial, marking a significant step forward in therapeutic advancements. https://youtu.be/YC-47svVwLM #TheBullRunShow #OTLC #Oncotelic #OTCQB #ArtificialIntelligence #Robotics #Manufacturing #Biotech #HealthTech #AIStocks #GrowthStocks #SmallCaps #TrendingStocks #StockMarket #MarketNews #Innovation
0 · Reply
Techallure
Techallure Jun. 29 at 2:55 PM
$OTLC Deciparticle platform The platform that will become a necessity to see any progress in many a pipeline.
0 · Reply
Techallure
Techallure Jun. 28 at 8:25 PM
$OTLC A parlay played with the joined technology of Roivant type companies and Oncotelic type companies makes all the difference and reduces the risk of failure to zero I ANTicipate some news forthcoming … who knows
0 · Reply
ckruel
ckruel Jun. 25 at 8:03 PM
$OTLC Insiders bought 25k dollar value in shares last qtr.
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 25 at 2:40 AM
$OTLC CEO purchased 255,000 shares at $0.04 for a total of $11,475. Trieu Vuong now owns 117,537,232 shares. https://ceo-buys.com
0 · Reply
Latest News on OTLC
No data available.
CEOBuysDisclosures
CEOBuysDisclosures Jul. 2 at 9:05 PM
$OTLC CEO purchased 240,000 shares at $0.04 for a total of $10,344. Trieu Vuong now owns 117,777,232 shares. https://ceo-buys.com
0 · Reply
WallStreetSignals
WallStreetSignals Jul. 2 at 5:07 PM
$OTLC 📢 Biotech Update Oncotelic Therapeutics ($OTLC) has published a peer-reviewed manuscript supporting its Deciparticle™ nanoparticle delivery platform, reinforcing the scientific foundation behind Sapu003, its investigational IV everolimus formulation now in a Phase 1b study. Worth keeping on your biotech watchlist. https://www.globenewswire.com/news-release/2026/06/29/3318946/0/en/oncotelic-announces-peer-reviewed-validation-of-deciparticle-platform-supporting-clinical-development-of-sapu003.html #OTLC #BiotechStocks #DrugDevelopment #Nanomedicine #ClinicalResearch #InvestSmart #StockNews #TheBullRunShow
0 · Reply
Techallure
Techallure Jul. 2 at 1:12 PM
$OTLC back to .03 before news
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 30 at 6:36 PM
From Hospitality to Pharma: TechForce Robotics Expanding Its Robotics-as-a-Service Platform into Laboratory Automation $NGTF $OTLC https://ibn.fm/0lbFE
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 29 at 3:46 PM
BioMedNewsBreaks — $OTLC Publishes Peer-Reviewed Validation of Deciparticle(TM) Platform https://ibn.fm/QTopP
0 · Reply
WallStreetSignals
WallStreetSignals Jun. 29 at 3:29 PM
$OTLC Breaking News | Oncotelic Therapeutics, Inc. (OTCQB: #OTLC) has published a peer-reviewed manuscript validating its innovative Deciparticle™ nanoparticle platform. This follows the development of Sapu003, an investigational intravenous formulation of everolimus currently in a Phase 1b clinical trial, marking a significant step forward in therapeutic advancements. https://youtu.be/YC-47svVwLM #TheBullRunShow #OTLC #Oncotelic #OTCQB #ArtificialIntelligence #Robotics #Manufacturing #Biotech #HealthTech #AIStocks #GrowthStocks #SmallCaps #TrendingStocks #StockMarket #MarketNews #Innovation
0 · Reply
Techallure
Techallure Jun. 29 at 2:55 PM
$OTLC Deciparticle platform The platform that will become a necessity to see any progress in many a pipeline.
0 · Reply
Techallure
Techallure Jun. 28 at 8:25 PM
$OTLC A parlay played with the joined technology of Roivant type companies and Oncotelic type companies makes all the difference and reduces the risk of failure to zero I ANTicipate some news forthcoming … who knows
0 · Reply
ckruel
ckruel Jun. 25 at 8:03 PM
$OTLC Insiders bought 25k dollar value in shares last qtr.
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 25 at 2:40 AM
$OTLC CEO purchased 255,000 shares at $0.04 for a total of $11,475. Trieu Vuong now owns 117,537,232 shares. https://ceo-buys.com
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 24 at 6:05 PM
NetworkNewsBreaks – $OTLC Eyes Opportunity Through AI and Pharmaceutical Automation https://nnw.fm/jtydH
0 · Reply
Techallure
Techallure Jun. 23 at 4:32 PM
$OTLC and $RDGL A power packed $1-$2 punch Be prepared Bein.. repaired
6 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 23 at 4:26 PM
The $410 Billion Drug Delivery Revolution: Why Drug Delivery May Be the Next Major Frontier in Oncology Innovation $OTLC https://ibn.fm/EImJf
0 · Reply
WallStreetSignals
WallStreetSignals Jun. 22 at 3:17 PM
$OTLC #OTLC Oncotelic Therapeutics, Inc. proudly unveils an innovative AI-powered GMP manufacturing services platform at the BIO International Convention 2026, paving the way for a transformative future in biopharmaceutical manufacturing. https://www.marketscreener.com/news/oncotelic-therapeutics-inc-launches-ai-powered-gmp-manufacturing-services-platform-at-bio-internat-ce7f5cddd081f525 #TheBullRunShow #Oncotelic #AIManufacturing #BIO2026 #Biopharma #Innovation @followers @highlight
0 · Reply
MikeTechnician
MikeTechnician Jun. 18 at 6:28 PM
$OTLC - The Platform leverages PDAOAI™, Oncotelic's proprietary AI architecture, to support: Electronic batch record generation and management AI-assisted manufacturing documentation GMP workflow digitization Quality and compliance support Manufacturing process monitoring Knowledge management and operational intelligence Integration with intelligent robotic systems through the Company's collaboration with TechForce C
0 · Reply
MikeTechnician
MikeTechnician Jun. 18 at 5:31 PM
$OTLC - Immunotherapies, Molecular Nanomedicine, and PDAOAI Drug Dev Platform. Advancing Cures Through Capital Efficient Partnerships https://www.oncotelic.com/#events
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 18 at 4:16 PM
InvestorNewsBreaks – $OTLC Launches AI-Powered GMP Manufacturing Services Platform at BIO 2026 https://ibn.fm/6PlnZ
0 · Reply
Crabtrees
Crabtrees Jun. 18 at 1:30 PM
$OTLC — Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026 https://finance.yahoo.com/healthcare/articles/oncotelic-launches-ai-powered-gmp-120000905.html
0 · Reply
MikeTechnician
MikeTechnician Jun. 18 at 12:54 PM
$OTLC Oncotelic Advances AI-Powered GMP Manufacturing Services Platform for Revenue-Generating AI and Robotics Manufacturing Services News link - https://otcmarkets.com/stock/OTLC/news/Oncotelic-Advances-AI-Powered-GMP-Manufacturing-Services-Platform-for-Revenue-Generating-AI-and-Robotics-Manufacturing-S?id=525372
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 18 at 1:40 AM
$OTLC CEO purchased 335,759 shares at $0.04 for a total of $15,013. Trieu Vuong now owns 117,282,232 shares. https://ceo-buys.com
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 17 at 7:04 PM
NetworkNewsBreaks – $OTLC Advances AI-Powered GMP Manufacturing Platform https://ibn.fm/YcBOt
0 · Reply
WallStreetSignals
WallStreetSignals Jun. 17 at 4:09 PM
$OTLC
0 · Reply